Association of FGFR4 Mutation With Immunotherapy Outcomes in Patients With Cancer

被引：0
|
作者：
Cui, L. [1 ]
Zhang, Y. [1 ]
Zhao, Z. [2 ]
Bai, Y. [1 ]
Liu, L. [3 ]
机构：
[1] 3D Med Inc, Dept Med, Shanghai, Peoples R China
[2] 3D Med Inc, Shanghai, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
FGFR4; immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P75.07
引用
收藏
页码：S576 / S576
页数：1
相关论文
共 50 条
  • [1] Targeting FGFR4 for rhabdomyosarcoma immunotherapy
    Cheuk, A. T. C.
    Shivaprasad, N.
    Kumar, J.
    Azorsa, P.
    Skarzynski, M.
    Baskar, S.
    Orentas, R.
    Khan, J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E9 - E10
  • [2] Identification of a novel oncogenic mutation of FGFR4 in gastric cancer
    Takashi Futami
    Tatsuya Kawase
    Kenichi Mori
    Makoto Asaumi
    Rumi Kihara
    Nobuaki Shindoh
    Sadao Kuromitsu
    Scientific Reports, 9
  • [3] Identification of a novel oncogenic mutation of FGFR4 in gastric cancer
    Futami, Takashi
    Kawase, Tatsuya
    Mori, Kenichi
    Asaumi, Makoto
    Kihara, Rumi
    Shindoh, Nobuaki
    Kuromitsu, Sadao
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [4] FGFR4 mutationas a novel biomarker for immunotherapy in patients with non-small cell lung cancer
    Jin, Xiangfeng
    Fan, Xinglong
    Tian, Kaihua
    Xu, Hanlin
    Ge, Nan
    Wang, Yafei
    Zhang, Shiyue
    Chen, Hui
    Yuan, Shaohua
    Wang, Kai
    CANCER RESEARCH, 2020, 80 (16)
  • [5] Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis
    L M FitzGerald
    E Karlins
    D M Karyadi
    E M Kwon
    J S Koopmeiners
    J L Stanford
    E A Ostrander
    Prostate Cancer and Prostatic Diseases, 2009, 12 : 192 - 197
  • [6] Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis
    FitzGerald, L. M.
    Karlins, E.
    Karyadi, D. M.
    Kwon, E. M.
    Koopmeiners, J. S.
    Stanford, J. L.
    Ostrander, E. A.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2009, 12 (02) : 192 - 197
  • [7] Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis
    Yang, Y. C.
    Lu, M. L.
    Rao, J. Y.
    Wallerand, H.
    Cai, L.
    Cao, W.
    Pantuck, A.
    Dalbagni, G.
    Reuter, V.
    Figlin, R. A.
    Belldegrun, A.
    Cordon-Cardo, C.
    Zhang, Z. F.
    BRITISH JOURNAL OF CANCER, 2006, 95 (11) : 1455 - 1458
  • [8] Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis
    Y C Yang
    M L Lu
    J Y Rao
    H Wallerand
    L Cai
    W Cao
    A Pantuck
    G Dalbagni
    V Reuter
    R A Figlin
    A Belldegrun
    C Cordon-Cardo
    Z F Zhang
    British Journal of Cancer, 2006, 95 : 1455 - 1458
  • [9] Targeting FGFR4 in colorectal cancer cells
    Heinzle, Christine
    Erdem, Zeynep
    Sonvilla, Gudrun
    Staettner, Stefan
    Karner, Josef
    Klimpfinger, Martin
    Grasl-Kraupp, Bettina
    Holzmann, Klaus
    Grusch, Michael
    Berger, Walter
    Marian, Brigitte
    CANCER RESEARCH, 2012, 72
  • [10] Analysis of patients with craniosynostosis syndromes for a Pro246Arg mutation in FGFR4
    Gaudenz, K
    Roessler, E
    Vainikka, S
    Alitalo, K
    Muenke, M
    MOLECULAR GENETICS AND METABOLISM, 1998, 64 (01) : 76 - 79
12345